Key facts
- This page summarizes Jane Ph D. Hsiao's Form 4 filing for ASENSUS SURGICAL, INC..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Jul 2021, 19:06.
Jane Ph D. Hsiao - 30 Jun 2021 Form 4 Insider Report for ASENSUS SURGICAL, INC.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 30 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 19:06:37 UTC
- Next SEC filing
- 10 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Weingard, as attorney-in-fact for Jane H. Hsiao
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jane Ph D. Hsiao filed Form 4 for ASENSUS SURGICAL, INC. on 02 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASXC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +29,231
- Change %
- +9.5%
- Price
- $0.000000
- Shares after
- 336,895
- Date
- 01 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2
ASXC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 96,746
- Date
- 30 Jun 2021
- Ownership
- Hsu Gamma Investments, L.P.
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASXC
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +3,748
- Change %
- Price
- $0.000000
- Shares after
- 3,748
- Date
- 30 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,748
- Exercise price
- $3.17
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Registrant's common stock.
Footnote F2
Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, provided that if the date of the 2022 annual meeting of stockholders is earlier, the restrictions will lapse on the date of the annual meeting.
Footnote F3
The Reporting Person is the general partner of Hsu Gama Investments, LP.
Footnote F4
Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended June 30, 2021.
Footnote F5
The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors.